この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1998/7/101 分で読めます
Antimicrobial Drugs and Resistance; Notice of Public Meeting
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing a public meeting to discuss the development of drug products for the treatment of resistant bacteria, including selective spectrum agents. The purpose of the meeting is to provide information on the agency's plans for future public scientific discussions of issues unique to the development of these drug products and to invite members of the public to provide comments on the agency's plans.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →